Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimen

Leuk Res. 2021 Jul:106:106583. doi: 10.1016/j.leukres.2021.106583. Epub 2021 Apr 22.

¹ Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, LA, USA. Electronic address: mibrahim1@tulane.edu.
² Deming Department of Medicine, Tulane University, New Orleans, LA, USA.
³ Department of Radiation Oncology, Tulane University, New Orleans, LA, USA.
⁴ Department of Pathology and Laboratory Medicine, Tulane University, New Orleans, LA, USA.
⁵ Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, LA, USA.

No abstract available

Publication types